Cure My Disease

Don't miss your cure!

 Log in / Sign up

Spinal stimulation may boost arm recovery in quadriplegia

NCT ID NCT07361627

Disease control Sponsor: Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jul 29, 2026 · Updated 7 times

Summary

This study tests whether combining spinal cord stimulation with physical therapy can improve arm and hand movement in people with cervical spinal cord injury. Forty participants will receive either real stimulation or a sham version during 20 therapy sessions over 6-8 weeks. Researchers will measure strength, hand function, and brain activity changes to see if the combination works better than therapy alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
transcutaneous spinal cord stimulation
What this could lead to
If it works, this could point toward a way to improve arm and hand function in people with spinal cord injury, helping them regain more independence.
What could go wrong
This is a small, early-stage trial with only 40 participants, so results may not apply to everyone. The improvement may be small or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Traumatic and non-traumatic spinal cord injury * Receiving in-patient rehabilitation * 16 years old or above * American Spinal Injury Association (ASIA) grade A to D * Neurological injury level between C5 and T2 * Residual upper limb motor impairments Exclusion Criteria: * Cardiac pacemaker * Active cancer at the stimulation site or metastatic cancer * Unstable lesion or clinical condition (e.g. respiratory issues) * Electrode placement is impossible due to unhealed wound or significant local pain * Other Neurological condition (e.g. Stroke, Parkinson's) * Chronic liver or kidney disease * Uncontrolled psychiatric condition * Life expectancy \< 6 months * Inability to provide informed consent (i.e., severe cognitive impairment, dementia, or Alzheimer's disease)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal cord injury (quadraplegia) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

quadriplegia spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spinal cord injury (quadraplegia) Spinal cord injury cervical Spinal cord injury, acute

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institut de réadaptation Gingras-Lindsay-de-Montréal (IRGLM)

    Montreal, Quebec, H3S 2J4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.